<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CPVT</z:e>) is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic condition</z:e> that presents with exercise-induced polymorphic <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a case report of a 25-year-old woman who had a <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> due to <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic analysis revealed a novel missense mutation in exon 90 of the <z:chebi fb="0" ids="8925">ryanodine</z:chebi> receptor (RyR2) gene resulting in substitution of arginine for serine at residue 4153 (S4153R) </plain></SENT>
<SENT sid="3" pm="."><plain>The patient received an implantable cardioverter-defibrillator and low-dose β-blocker therapy </plain></SENT>
<SENT sid="4" pm="."><plain>She had recurrent polymorphic <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> treated with appropriate cardioverter-defibrillator shocks and <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Titration of β-blocker to a much higher dose suppressed further episodes of <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> and <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo>, resulting in reduction in device therapies </plain></SENT>
</text></document>